Moderna's mRNA cancer vaccine breakthrough with Merck fueled a biotech rally, with the IBB near highs. Eli Lilly and Natera ...

A major biotech firm is axing hundreds of jobs, and Bay Area employees are bearing the brunt of the latest cuts. Genentech, one of the world's largest biotechnology companies and a subsidiary of Swiss ...

Intuitively, the case for biotechnology-related investments comes across rather obviously: the concept of healthcare should be a permanent one. And because of this permanence, the expected market ...

Biotechnology investors remain confident in the sector's outlook even after a major comeback this year — and they're picking their positions. The healthcare subsector has quietly become one of the ...

In the world of biotechnology investing, companies often struggle to bring new drugs to market. Developing treatments for rare diseases can be incredibly expensive, and because these conditions affect ...